Bone Density Decline: Tenofovir has long been connected to a lessen in bone mineral density, escalating the risk of bone problems or fractures.HIV-1 infected subjects on dolutegravir monotherapy demonstrated swift and dose-dependent reduction of antiviral activity with declines of HIV-1 RNA copies for every ml. The antiviral response was managed fo… Read More